Battelle, Andelyn Biosciences, and AmplifyBio Awarded Task Orders for Plasmid and Suspension AAV Vector Manufacturing and IND-enabling Studies from the National Institute of Neurological Disorders and Stroke (NINDS)
COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle, Andelyn Biosciences, Inc., and AmplifyBio, have been awarded a new task order from the National Institute of Neurological Disorders and Stroke (NINDS) to manufacture suspension process gene therapy for the transformative treatment of Aspartylglucosaminuria (AGU). Battelle is the world’s largest independent nonprofit research and development organization; Andelyn Biosciences, Inc. is a pioneering and patient focused cell and gene therapy Contract Develo
Nov 20, 2023
